CanSino Biologics (Germany) Analysis

CJH Stock   3.60  0.24  7.14%   
CanSino Biologics is overvalued with Real Value of 3.38 and Hype Value of 3.6. The main objective of CanSino Biologics stock analysis is to determine its intrinsic value, which is an estimate of what CanSino Biologics is worth, separate from its market price. There are two main types of CanSino Biologics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect CanSino Biologics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of CanSino Biologics' stock to identify patterns and trends that may indicate its future price movements.
The CanSino Biologics stock is traded in Germany on Stuttgart Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. CanSino Biologics is usually not traded on GermanUnityDay, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. CanSino Stock trading window is adjusted to Europe/Berlin timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CanSino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

CanSino Stock Analysis Notes

About 27.0% of the company shares are held by company insiders. The book value of CanSino Biologics was currently reported as 29.22. The company last dividend was issued on the 13th of July 2022. For more info on CanSino Biologics please contact the company at 400 922 2099 or go to https://www.cansinotech.com.

CanSino Biologics Investment Alerts

CanSino Biologics is way too risky over 90 days horizon
CanSino Biologics appears to be risky and price may revert if volatility continues
About 27.0% of the company shares are held by company insiders

CanSino Biologics Thematic Classifications

In addition to having CanSino Biologics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Soft Drinks Idea
Soft Drinks
Soft drinks beverages and refreshments

CanSino Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CanSino Biologics's market, we take the total number of its shares issued and multiply it by CanSino Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 3rd of December, CanSino Biologics shows the Mean Deviation of 3.62, downside deviation of 5.16, and Risk Adjusted Performance of 0.1528. CanSino Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CanSino Biologics Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CanSino Biologics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CanSino Biologics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

CanSino Biologics Outstanding Bonds

CanSino Biologics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CanSino Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CanSino bonds can be classified according to their maturity, which is the date when CanSino Biologics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

CanSino Biologics Predictive Daily Indicators

CanSino Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CanSino Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

CanSino Biologics Forecast Models

CanSino Biologics' time-series forecasting models are one of many CanSino Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CanSino Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding CanSino Biologics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Additional Tools for CanSino Stock Analysis

When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.